• Je něco špatně v tomto záznamu ?

Economic analysis of acupuncture for migraine prophylaxis

J. Pokladnikova, P. Maresova, J. Dolejs, AL. Park, B. Wang, X. Guan, F. Musil,

. 2018 ; 14 (-) : 3053-3061. [pub] 20181112

Jazyk angličtina Země Nový Zéland

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19001473

Background: Acupuncture has become a viable option for migraine prophylaxis in Europe; however, despite its wide use, more data on the short- and long-term cost-effectiveness are needed when considering the perspectives of a paying third-party, the patient, and of society in general. The aim was to evaluate the cost and effectiveness of adjuvant acupuncture to pharmacologic treatment vs pharmacologic treatment alone in migraine patients after a 3-month acupuncture course and a 6-month follow-up from all perspectives. Methods: The study involved an open-label randomized clinical trial of patients receiving acupuncture (n=42), and a waiting list control group (n=44). The number of migraine days during the last 28 days, as well as direct and indirect costs were considered. The trial was registered under DRKS00009803. Results: The total cost per patient reached €696 vs €285 after 3 months of acupuncture and €66 vs €132 in the acupuncture and control groups after a 6-month follow-up, respectively (P=0.071). The trends observed in effectiveness and costs from all perspectives are discussed. Conclusion: The inclusion of acupuncture in health care results beneficial mainly for its observed trend in reduced losses of productivity and income, with the latter often exceeding the costs of acupuncture treatment. As such, acupuncture may be recommended as an adjuvant treatment in migraine prophylaxis to standard pharmacotherapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19001473
003      
CZ-PrNML
005      
20190108130758.0
007      
ta
008      
190107s2018 nz f 000 0|eng||
009      
AR
024    7_
$a 10.2147/NDT.S174870 $2 doi
035    __
$a (PubMed)30519026
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a nz
100    1_
$a Pokladnikova, Jitka $u Czech-Chinese Centre for Traditional Chinese Medicine, University Hospital in Hradec Kralove, Hradec Kralove, Czech Republic, jitka.pokladnikova@faf.cuni.cz. Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic, jitka.pokladnikova@faf.cuni.cz.
245    10
$a Economic analysis of acupuncture for migraine prophylaxis / $c J. Pokladnikova, P. Maresova, J. Dolejs, AL. Park, B. Wang, X. Guan, F. Musil,
520    9_
$a Background: Acupuncture has become a viable option for migraine prophylaxis in Europe; however, despite its wide use, more data on the short- and long-term cost-effectiveness are needed when considering the perspectives of a paying third-party, the patient, and of society in general. The aim was to evaluate the cost and effectiveness of adjuvant acupuncture to pharmacologic treatment vs pharmacologic treatment alone in migraine patients after a 3-month acupuncture course and a 6-month follow-up from all perspectives. Methods: The study involved an open-label randomized clinical trial of patients receiving acupuncture (n=42), and a waiting list control group (n=44). The number of migraine days during the last 28 days, as well as direct and indirect costs were considered. The trial was registered under DRKS00009803. Results: The total cost per patient reached €696 vs €285 after 3 months of acupuncture and €66 vs €132 in the acupuncture and control groups after a 6-month follow-up, respectively (P=0.071). The trends observed in effectiveness and costs from all perspectives are discussed. Conclusion: The inclusion of acupuncture in health care results beneficial mainly for its observed trend in reduced losses of productivity and income, with the latter often exceeding the costs of acupuncture treatment. As such, acupuncture may be recommended as an adjuvant treatment in migraine prophylaxis to standard pharmacotherapy.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Maresova, Petra $u Faculty of Informatics and Management, University of Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Dolejs, Josef $u Faculty of Informatics and Management, University of Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Park, A-La $u Personal Social Services Research Unit, Department of Health Policy, London School of Economics and Political Science, London, UK.
700    1_
$a Wang, Bo $u Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
700    1_
$a Guan, Xin $u Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
700    1_
$a Musil, Frantisek $u Czech-Chinese Centre for Traditional Chinese Medicine, University Hospital in Hradec Kralove, Hradec Kralove, Czech Republic, jitka.pokladnikova@faf.cuni.cz.
773    0_
$w MED00183034 $t Neuropsychiatric disease and treatment $x 1176-6328 $g Roč. 14, č. - (2018), s. 3053-3061
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30519026 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190108130959 $b ABA008
999    __
$a ind $b bmc $g 1365298 $s 1039596
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 14 $c - $d 3053-3061 $e 20181112 $i 1176-6328 $m Neuropsychiatric disease and treatment $n Neuropsychiatr Dis Treat $x MED00183034
LZP    __
$a Pubmed-20190107

Najít záznam

Citační ukazatele

Možnosti archivace